Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Open Label Study of Abiraterone Acetate in Advanced Prostate Cancer After Androgen Deprivation and Docetaxel
2006-004571-36Phase 2Completed
- Sponsor
- Cougar Biotechnology
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abiraterone in prostate cancer (PCa), sponsored by Cougar Biotechnology. Primary endpoint: Serum PSA decline. Started Oct 2006; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-004571-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004571-36.